-
Founded in:
1996-10-03 -
Country:
China -
Address:
No. 108, Shuxi Road, Jinniu District, Chengdu, Sichuan -
Tax NO.:
91510100633116839D -
Registered Funds:
919.463954 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Aripiprazole |
It has high affinity for D2, D3, 5-HT1A, and 5-HT2A receptors, and moderate affinity for D4, 5-HT2C, 5-HT7, α1, H1 receptors, and 5-HT reabsorption sites. It is a partial agonist of D2 and 5-HT1A receptors, and an antagonist of 5-HT2A receptors. Its mechanism of action may be mediated by partial agonism of D2 and 5-HT1A receptors and antagonism of 5-HT2A receptors. The action with other receptors may produce some other clinical effects, such as the antagonism of α1 receptors, which can explain the phenomenon of postural hypotension.
More
It has high affinity for D2, D3, 5-HT1A, and 5-HT2A receptors, and moderate affinity for D4, 5-HT2C, 5-HT7, α1, H1 receptors, and 5-HT reabsorption sites. It is a partial agonist of D2 and 5-HT1A receptors, and an antagonist of 5-HT2A receptors. Its mechanism of action may be mediated by partial agonism of D2 and 5-HT1A receptors and antagonism of 5-HT2A receptors. The action with other receptors may produce some other clinical effects, such as the antagonism of α1 receptors, which can explain the phenomenon of postural hypotension. |
129722-12-9 | 82 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Aripiprazole |
It has high affinity for D2, D3, 5-HT1A, and 5-HT2A receptors, and moderate affinity for D4, 5-HT2C, 5-HT7, α1, H1 receptors, and 5-HT reabsorption sites. It is a partial agonist of D2 and 5-HT1A receptors, and an antagonist of 5-HT2A receptors. Its mechanism of action may be mediated by partial agonism of D2 and 5-HT1A receptors and antagonism of 5-HT2A receptors. The action with other receptors may produce some other clinical effects, such as the antagonism of α1 receptors, which can explain the phenomenon of postural hypotension.
More
It has high affinity for D2, D3, 5-HT1A, and 5-HT2A receptors, and moderate affinity for D4, 5-HT2C, 5-HT7, α1, H1 receptors, and 5-HT reabsorption sites. It is a partial agonist of D2 and 5-HT1A receptors, and an antagonist of 5-HT2A receptors. Its mechanism of action may be mediated by partial agonism of D2 and 5-HT1A receptors and antagonism of 5-HT2A receptors. The action with other receptors may produce some other clinical effects, such as the antagonism of α1 receptors, which can explain the phenomenon of postural hypotension. |
129722-12-9 | 82 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Wild peony |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| GLEDITSIAE FRUCTUS ABNORMALIS |
|
0 | ||
| Asari Radix et Rhizoma |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Venlafaxine hydrochloride |
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.
More
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft. |
99300-78-4 | 84 |